List of works - Marco Rusnati

Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis

scientific article

Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors

scientific article published in May 2005

Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size

scientific article (publication date: 25 April 1997)

Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis

scientific article published on 18 March 2004

Role of the soluble pattern recognition receptor PTX3 in vascular biology

scientific article published on July 2007

Multiple interactions of HIV-I Tat protein with size-defined heparin oligosaccharides

scientific article (publication date: October 1999)

Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies

scientific article published on January 2007

Cutting edge: proangiogenic properties of alternatively activated dendritic cells.

scientific article published in September 2005

Identification of an antiangiogenic FGF2-binding site in the N terminus of the soluble pattern recognition receptor PTX3.

scientific article published on 12 June 2006

Endogenous Basic Fibroblast Growth Factor Is Implicated in the Vascularization of the Chick Embryo Chorioallantoic Membrane

scientific article published on July 1, 1995

Pradimicin A, a carbohydrate-binding nonpeptidic lead compound for treatment of infections with viruses with highly glycosylated envelopes, such as human immunodeficiency virus

scientific article published on 18 October 2006

Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans. Biological implications in neovascularization.

scientific article

Cell membrane GM1 ganglioside is a functional coreceptor for fibroblast growth factor 2

scientific article

HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2.

scientific article

HIV-1 Tat protein and endothelium: from protein/cell interaction to AIDS-associated pathologies.

scientific article

The Basic Domain in HIV-1 Tat Protein as a Target for Polysulfonated Heparin-mimicking Extracellular Tat Antagonists

scientific article published on June 26, 1998

Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo

scientific article published on 14 July 2005

Undersulfated and glycol-split heparins endowed with antiangiogenic activity

scientific article published in February 2004

Thrombospondin 1 as a scavenger for matrix-associated fibroblast growth factor 2

scientific article published on 28 August 2003

Heparin derivatives as angiogenesis inhibitors

scientific article

Short heparin sequences spaced by glycol-split uronate residues are antagonists of fibroblast growth factor 2 and angiogenesis inhibitors

scientific article

The discovery of basic fibroblast growth factor/fibroblast growth factor-2 and its role in haematological malignancies.

scientific article

Non-peptidic thrombospondin-1 mimics as fibroblast growth factor-2 inhibitors: an integrated strategy for the development of new antiangiogenic compounds

scientific article

Integrin alphavbeta3 as a target for blocking HIV-1 Tat-induced endothelial cell activation in vitro and angiogenesis in vivo.

scientific article published on 15 September 2005

Heparan sulfate proteoglycans mediate the angiogenic activity of the vascular endothelial growth factor receptor-2 agonist gremlin.

scientific article published on 15 September 2011

Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis.

scientific article published on January 1998

Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.

scientific article published on 10 April 2015

Membrane association of peroxiredoxin-2 in red cells is mediated by the N-terminal cytoplasmic domain of band 3.

scientific article

Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain

scientific article

HIV-1 Tat and heparan sulfate proteoglycan interaction: a novel mechanism of lymphocyte adhesion and migration across the endothelium

scientific article

Fibroblast growth factors and their receptors in hematopoiesis and hematological tumors

scientific article

Targeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitors

scientific article published on November 1, 2010

Identification of a dendrimeric heparan sulfate-binding peptide that inhibits infectivity of genital types of human papillomaviruses.

scientific article

Undersulfated, low-molecular-weight glycol-split heparin as an antiangiogenic VEGF antagonist

scientific article published on 20 October 2004

alpha(v)beta3-integrin-dependent activation of focal adhesion kinase mediates NF-kappaB activation and motogenic activity by HIV-1 Tat in endothelial cells

scientific article published on 16 August 2005

HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation.

scientific article published on 18 January 2012

Biotechnological engineering of heparin/heparan sulphate: a novel area of multi-target drug discovery.

scientific article

Activation of Hsp90 Enzymatic Activity and Conformational Dynamics through Rationally Designed Allosteric Ligands.

scientific article published on 18 August 2015

Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 Tat and gp120 proteins

scientific article published on 23 April 2007

Polyanionic drugs and viral oncogenesis: a novel approach to control infection, tumor-associated inflammation and angiogenesis.

scientific article

Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists

scientific article published in June 2004

Thrombospondin-1 inhibits Kaposi's sarcoma (KS) cell and HIV-1 Tat-induced angiogenesis and is poorly expressed in KS lesions

article

Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts

scientific article

Sulfated K5 Escherichia coli polysaccharide derivatives as wide-range inhibitors of genital types of human papillomavirus.

scientific article published on 4 February 2008

A complex of α6 integrin and E-cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin-like 6

scientific article

Purification of basic fibroblast growth factor from rat brain: identification of a Mr 22,000 immunoreactive form

scientific article published on September 1988

Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide.

scientific article

Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action.

scientific article

Simian immunodeficiency virus and human immunodeficiency virus type 1 matrix proteins specify different capabilities to modulate B cell growth

scientific article

Polysulfated/sulfonated compounds for the development of drugs at the crossroad of viral infection and oncogenesis.

scientific article published on January 2009

List of works by Marco Rusnati

Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis

Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors

Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size

Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis

Role of the soluble pattern recognition receptor PTX3 in vascular biology

Multiple interactions of HIV-I Tat protein with size-defined heparin oligosaccharides

Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies

Cutting edge: proangiogenic properties of alternatively activated dendritic cells.

Identification of an antiangiogenic FGF2-binding site in the N terminus of the soluble pattern recognition receptor PTX3.

Endogenous Basic Fibroblast Growth Factor Is Implicated in the Vascularization of the Chick Embryo Chorioallantoic Membrane

Pradimicin A, a carbohydrate-binding nonpeptidic lead compound for treatment of infections with viruses with highly glycosylated envelopes, such as human immunodeficiency virus

Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans. Biological implications in neovascularization.

Cell membrane GM1 ganglioside is a functional coreceptor for fibroblast growth factor 2

HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2.

HIV-1 Tat protein and endothelium: from protein/cell interaction to AIDS-associated pathologies.

The Basic Domain in HIV-1 Tat Protein as a Target for Polysulfonated Heparin-mimicking Extracellular Tat Antagonists

Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo

Undersulfated and glycol-split heparins endowed with antiangiogenic activity

Thrombospondin 1 as a scavenger for matrix-associated fibroblast growth factor 2

Heparin derivatives as angiogenesis inhibitors

Short heparin sequences spaced by glycol-split uronate residues are antagonists of fibroblast growth factor 2 and angiogenesis inhibitors

The discovery of basic fibroblast growth factor/fibroblast growth factor-2 and its role in haematological malignancies.

Non-peptidic thrombospondin-1 mimics as fibroblast growth factor-2 inhibitors: an integrated strategy for the development of new antiangiogenic compounds

Integrin alphavbeta3 as a target for blocking HIV-1 Tat-induced endothelial cell activation in vitro and angiogenesis in vivo.

Heparan sulfate proteoglycans mediate the angiogenic activity of the vascular endothelial growth factor receptor-2 agonist gremlin.

Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis.

Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.

Membrane association of peroxiredoxin-2 in red cells is mediated by the N-terminal cytoplasmic domain of band 3.

Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain

HIV-1 Tat and heparan sulfate proteoglycan interaction: a novel mechanism of lymphocyte adhesion and migration across the endothelium

Fibroblast growth factors and their receptors in hematopoiesis and hematological tumors

Targeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitors

Identification of a dendrimeric heparan sulfate-binding peptide that inhibits infectivity of genital types of human papillomaviruses.

Undersulfated, low-molecular-weight glycol-split heparin as an antiangiogenic VEGF antagonist

alpha(v)beta3-integrin-dependent activation of focal adhesion kinase mediates NF-kappaB activation and motogenic activity by HIV-1 Tat in endothelial cells

HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation.

Biotechnological engineering of heparin/heparan sulphate: a novel area of multi-target drug discovery.

Activation of Hsp90 Enzymatic Activity and Conformational Dynamics through Rationally Designed Allosteric Ligands.

Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 Tat and gp120 proteins

Polyanionic drugs and viral oncogenesis: a novel approach to control infection, tumor-associated inflammation and angiogenesis.

Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists

Thrombospondin-1 inhibits Kaposi's sarcoma (KS) cell and HIV-1 Tat-induced angiogenesis and is poorly expressed in KS lesions

Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts

Sulfated K5 Escherichia coli polysaccharide derivatives as wide-range inhibitors of genital types of human papillomavirus.

A complex of α6 integrin and E-cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin-like 6

Purification of basic fibroblast growth factor from rat brain: identification of a Mr 22,000 immunoreactive form

Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide.

Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action.

Simian immunodeficiency virus and human immunodeficiency virus type 1 matrix proteins specify different capabilities to modulate B cell growth

Polysulfated/sulfonated compounds for the development of drugs at the crossroad of viral infection and oncogenesis.